Cholesterol overload in the liver aggravates oxidative stress-mediated DNA damage and accelerates hepatocarcinogenesis

Primary liver cancers represent the second leading cause of cancer-related deaths worldwide. Diverse etiological factors include chronic viral hepatitis, aflatoxin and alcohol exposure as well as aberrant liver lipid overload. Cholesterol has been identified as a key inducer of metabolic impairment, oxidative stress and promoter of cellular dysfunction. The aim of this work was to address the oxidative stress-mediated DNA damage induced by cholesterol overload, and its role in the development of hepatocellular carcinoma. C57BL/6 male mice were fed with a high cholesterol diet, followed by a single dose of N-diethylnitrosamine (DEN, 10 μg/g, ip). Reactive oxygen species generation, DNA oxidation, antioxidant and DNA repair proteins were analyzed at different time points. Diet-induced cholesterol overload caused enhanced oxidative DNA damage in the liver and was associated with a decrease in key DNA repair genes as early as 7 days. Interestingly, we found a cell survival response, induced by cholesterol, judged by a decrement in Bax to Bcl2 ratio. Importantly, N-acetyl-cysteine supplementation significantly prevented DNA oxidation damage. Furthermore, at 8 months after DEN administration, tumor growth was significantly enhanced in mice under cholesterol diet in comparison to control animals. Together, these results suggest that cholesterol overload exerts an oxidative stress-mediated effects and promotes the development of liver cancer.

[1]  L. Terracciano,et al.  Liver damage and senescence increases in patients developing hepatocellular carcinoma , 2017, Journal of gastroenterology and hepatology.

[2]  Xiangjian Luo,et al.  Emerging roles of lipid metabolism in cancer metastasis , 2017, Molecular Cancer.

[3]  D. Calvisi,et al.  Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma , 2017, Cell cycle.

[4]  D. Calvisi,et al.  Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[5]  Wen-Hong Wang,et al.  Genetic alterations in hepatocellular carcinoma: An update , 2016, World journal of gastroenterology.

[6]  L. Gómez-Quiroz,et al.  Liver Cholesterol Overload Aggravates Obstructive Cholestasis by Inducing Oxidative Stress and Premature Death in Mice , 2016, Oxidative medicine and cellular longevity.

[7]  J. Fernandez-Checa,et al.  Mitochondria, cholesterol and cancer cell metabolism , 2016, Clinical and Translational Medicine.

[8]  Isabel R Schlaepfer,et al.  Aberrant Lipid Metabolism Promotes Prostate Cancer: Role in Cell Survival under Hypoxia and Extracellular Vesicles Biogenesis , 2016, International journal of molecular sciences.

[9]  S. Thorgeirsson,et al.  Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stress. , 2016, Toxicology.

[10]  J. Dufour,et al.  Surveillance for Hepatocellular Carcinoma in Patients with NASH , 2016, Diagnostics.

[11]  Ji‐Xin Cheng,et al.  Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer , 2016, Oncogene.

[12]  Jie Liu,et al.  Simvastatin blocks TGF-β1-induced epithelial-mesenchymal transition in human prostate cancer cells. , 2016, Oncology letters.

[13]  L. Gómez-Quiroz,et al.  Hepatocyte Growth Factor Reduces Free Cholesterol-Mediated Lipotoxicity in Primary Hepatocytes by Countering Oxidative Stress , 2016, Oxidative medicine and cellular longevity.

[14]  S. Beloribi-Djefaflia,et al.  Lipid metabolic reprogramming in cancer cells , 2016, Oncogenesis.

[15]  S. Costantini,et al.  GPX4 and GPX7 Over-Expression in Human Hepatocellular Carcinoma Tissues , 2015, European journal of histochemistry : EJH.

[16]  A. Ryan,et al.  ATM and ATR as therapeutic targets in cancer. , 2015, Pharmacology & therapeutics.

[17]  Lucas B. Sullivan,et al.  Mitochondrial reactive oxygen species and cancer , 2014, Cancer & Metabolism.

[18]  P. Schumacker,et al.  Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? , 2014, Nature Reviews Cancer.

[19]  H. Bartsch,et al.  The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts , 2014, Redox biology.

[20]  H. Kalbacher,et al.  De novo lipogenesis in health and disease. , 2014, Metabolism: Clinical and Experimental.

[21]  D. Kershenobich,et al.  Acetaldehyde targets superoxide dismutase 2 in liver cancer cells inducing transient enzyme impairment and a rapid transcriptional recovery. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[22]  P. Nielsen,et al.  Detection and interpretation of 8-oxodG and 8-oxoGua in urine, plasma and cerebrospinal fluid. , 2014, Biochimica et biophysica acta.

[23]  M. Kudo,et al.  Reactive Oxygen Species Induce Epigenetic Instability through the Formation of 8-Hydroxydeoxyguanosine in Human Hepatocarcinogenesis , 2013, Digestive Diseases.

[24]  L. Zou,et al.  DNA damage sensing by the ATM and ATR kinases. , 2013, Cold Spring Harbor perspectives in biology.

[25]  L. Gómez-Quiroz,et al.  Hepatocyte growth factor protects against isoniazid/rifampicin-induced oxidative liver damage. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  S. Thorgeirsson,et al.  Biphasic regulation of the NADPH oxidase by HGF/c-Met signaling pathway in primary mouse hepatocytes. , 2013, Biochimie.

[27]  A. Colell,et al.  Hepatocarcinogenesis and ceramide/cholesterol metabolism. , 2012, Anti-cancer agents in medicinal chemistry.

[28]  Fan Mo,et al.  RNA-Seq Analyses Generate Comprehensive Transcriptomic Landscape and Reveal Complex Transcript Patterns in Hepatocellular Carcinoma , 2011, PloS one.

[29]  D. Calvisi,et al.  Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. , 2011, Gastroenterology.

[30]  A. Zentella,et al.  Bcl-2 sustains hormetic response by inducing Nrf-2 nuclear translocation in L929 mouse fibroblasts. , 2010, Free radical biology & medicine.

[31]  H. Waldmann,et al.  The lipid modifications of Ras that sense membrane environments and induce local enrichment. , 2009, Angewandte Chemie.

[32]  J. Fernandez-Checa,et al.  Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. , 2009, Journal of hepatology.

[33]  M. Nakanishi,et al.  8‐Hydroxy‐2′‐deoxy‐guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection , 2008, Journal of gastroenterology and hepatology.

[34]  J. Prieto,et al.  Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma. , 2008, Cancer research.

[35]  J. Hayashi,et al.  ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis , 2008, Science.

[36]  S. Thorgeirsson,et al.  Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis. , 2007, Cancer research.

[37]  A. Richardson,et al.  Gpx4 protects mitochondrial ATP generation against oxidative damage. , 2007, Biochemical and biophysical research communications.

[38]  A. Colell,et al.  Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. , 2006, Cell metabolism.

[39]  S. Thorgeirsson,et al.  Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. , 2006, The Journal of clinical investigation.

[40]  Dimitris Kletsas,et al.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.

[41]  T. Ørntoft,et al.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.

[42]  R. Schiestl,et al.  Effect of N-Acetyl Cysteine on Oxidative DNA Damage and the Frequency of DNA Deletions in Atm-Deficient Mice , 2004, Cancer Research.

[43]  Ken‐ichi Yamamoto,et al.  Protective roles for ATM in cellular response to oxidative stress , 2000, FEBS letters.

[44]  Henry R. Bourne,et al.  Lipid Modifications of Trimeric G Proteins (*) , 1995, The Journal of Biological Chemistry.

[45]  S. Aust,et al.  Microsomal lipid peroxidation. , 1978, Methods in enzymology.